Evidence map›Paper›PMID 41632694›Full record

ArticleBlood advances2026

Effectiveness of health care transition interventions for sickle cell disease.

Melissa Azul, Tarun Aurora, Jerlym Porter, Sheila Anderson, Marquita Nelson, Ugochi O Ogu, Parul Rai, Yogindra Persaud, Jennifer Longoria, Andrew Heitzer and 5 more

Abstract read
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Melissa AzulDivision of Hematology, Oncology, and Bone Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0001-6982-0400
Tarun AuroraDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
Jerlym PorterDepartment of Psycholoy and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-0173-6522
Sheila AndersonDivision of Clinical Hematology, Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Marquita NelsonDivision of Hematology, University of Tennessee Health Science Center, Memphis, TN.
Ugochi O OguDivision of Hematology, University of Tennessee Health Science Center, Memphis, TN.ORCID 0000-0002-4662-1414
Parul RaiDivision of Clinical Hematology, Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-5770-7280
Yogindra PersaudDivision of Clinical Hematology, Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0009-0007-5703-8172
Jennifer LongoriaDepartment of Psycholoy and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-0621-6438
Andrew HeitzerDepartment of Psycholoy and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-0582-3850
Martha BartonDivision of Clinical Hematology, Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0009-0003-1625-8284
Yunusa OlufadiDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-7187-7585
Ana A BaumannDepartment of Surgery, Washington University, St. Louis, MO.ORCID 0000-0002-4523-0147
Guolian KangDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN.
Jane S HankinsDivision of Clinical Hematology, Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-4439-7321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractEffective transition programs are essential for adolescents and young adults with sickle cell disease (SCD), yet their long-term impact remains unexplored. The St. Jude SCD Transition Program provides structured transition interventions, such as disease education, personal health record (PHR) communication training, transition skills-building, academic guidance, and early adult care introduction for patients aged 12 to 25 years. This 13-year retrospective cohort study evaluated program effectiveness on first adult visit attendance, successful transfer to adult care, adult ambulatory and acute care use, and health-related quality of life (HRQOL). Among 638 patients, 74.5% attended their first adult visit and 40.0% successfully transferred to adult care (2 visits within the first year after transfer). Increased participation in nearly all transition interventions was associated with first adult visit attendance, and all interventions were associated with successful transfer. In-person SCD education and early introduction to adult care were independently associated with first adult visit attendance, whereas in-person SCD education and PHR training were independently associated with successful transfer. A predictive model incorporating intervention exposure and demographics yielded an area under the curve of 0.81 for attendance at the first adult visit (95% confidence interval, 0.75-0.88; sensitivity 0.76, specificity 0.70). PHR training was associated with adult ambulatory use up to 3 years after transfer and improved early adulthood HRQOL. No interventions were associated with acute care use. Transition interventions that improve disease literacy, communication, and care transfer processes are linked to better transition outcomes and HRQOL, though sustained adult care engagement remains low. Future research is needed to promote adult care engagement.

Indexed as

Anemia, Sickle CellTransition to Adult CareAdolescentAdultChildFemaleHumansMaleQuality of LifeRetrospective StudiesYoung Adult

Identifiers

PMID41632694
PMCPMC13235466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.